Evidence map›Paper›PMID 31675963›Full record

SynthesisBMC health services research2019

The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.

Emily Rhodes, Maria Wilson, Alysia Robinson, Jill A Hayden, Mark Asbridge

Abstract readSystematic Review
In one paragraph

Synthesis in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Establishment of a Novel Approach for Drug Abuse Monitoring and Its Application in Medical Institutions.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects of state opioid prescribing laws on rates of fatal crashes in the USA.Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention · 2025
    Article
  12. Article
  13. Article
  14. Delivering MOUD to the Underserved: How Can Pharmacies Really Help?Journal of studies on alcohol and drugs · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Accelerating Solutions for the Overdose Crisis: an Effectiveness-Implementation Hybrid Protocol for the HEAL Prevention Cooperative.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
  20. Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily RhodesDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, NS, Canada.
Maria WilsonDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, NS, Canada.
Alysia RobinsonDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, NS, Canada.
Jill A HaydenDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, NS, Canada.
Mark AsbridgeDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, NS, Canada. mark.asbridge@dal.ca.

Funding

CIHR 397982
6 · The paper itself

Abstract

backgroundIn order to address the opioid crisis in North America, many regions have adopted preventative strategies, such as prescription drug monitoring programs (PDMPs). PDMPs aim to increase patient safety by certifying that opioids are prescribed in appropriate quantities. We aimed to synthesize the literature on changes in opioid-related harms and consequences, an important measure of PDMP effectiveness.

methodsWe completed a systematic review. We conducted a narrative synthesis of opioid-related harms and consequences from PDMP implementation. Outcomes were grouped into categories by theme: opioid dependence, opioid-related care outcomes, opioid-related adverse events, and opioid-related legal and crime outcomes.

resultsWe included a total of 22 studies (49 PDMPs) in our review. Two studies reported on illicit and problematic use but found no significant associations with PDMP status. Eight studies examined the association between PDMP status and opioid-related care outcomes, of which two found that treatment admissions for prescriptions opioids were lower in states with PDMP programs (p < 0.05). Of the thirteen studies that reported on opioid-related adverse events, two found significant (p < 0.001 and p < 0.05) but conflicting results with one finding a decrease in opioid-related overdose deaths after PDMP implementation and the other an increase. Lastly, two studies found no statistically significant association between PDMP status and opioid-related legal and crime outcomes (crime rates, identification of potential dealers, and diversion).

conclusionOur study found limited evidence to support overall associations between PDMPs and reductions in opioid-related consequences. However, this should not detract from the value of PDMPs' larger role of improving opioid prescribing.

Indexed as

Prescription Drug Monitoring ProgramsHumansOpioid-Related DisordersProgram EvaluationRandomized Controlled Trials as TopicConsequencesHarmsOpioidsPrescription drug monitoring programs

Identifiers

PMID31675963
PMCPMC6825333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.